Detalhe da pesquisa
1.
Novel approaches to target HER2-positive breast cancer: trastuzumab emtansine.
Cancer Manag Res
; 8: 57-65, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27274311
2.
Role of Anti-HER-2 Therapies in the Neo-Adjuvant Setting: Is Complete Pathological Response a Solid Surrogate?
Rev Recent Clin Trials
; 10(2): 82-9, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26216436
3.
Anti-Hormonal Therapies for Premenopausal Patients--What did we Learn from the TEXT/SOFT Trials?
Rev Recent Clin Trials
; 10(2): 90-100, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26216437
4.
Recent treatment advances and novel therapies in pancreas cancer: a review.
J Gastrointest Cancer
; 45(2): 190-201, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24343588
5.
Therapeutic options for HER-2 positive breast cancer: Perspectives and future directions.
World J Clin Oncol
; 5(3): 440-54, 2014 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25114858
6.
Advances and new perspectives in the treatment of metastatic colon cancer.
World J Gastrointest Oncol
; 6(7): 211-24, 2014 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25024813
7.
Novel targeted agents for the treatment of advanced breast cancer.
Future Med Chem
; 4(7): 893-914, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22571614
8.
Trastuzumab subcutaneo en el tratamiento del cancer de mama HER2 positivo / Subcutaneous trastuzumab in breastcancer treatment of her2 positive
Oncol. clín
; 21(1): 1-8, mar. 2016. tab
Artigo
em Espanhol
| LILACS | ID: biblio-835108
9.
Tratamiento medico del cancer colorrectal / Medical treatment of colorectal cancer
Medicina (B.Aires)
; 56(4): 414-22, 1996. tab
Artigo
em Espanhol
| LILACS | ID: lil-186265